Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
Lantheus
LNTH
US OptionsDetailed Quotes
OM250516P1000
- 0.50
- 0.000.00%
15min DelayClose Mar 19 16:00 ET
0.00High0.00Low
0.00Open0.50Pre Close0 Volume3.10K Open Interest1.00Strike Price0.00Turnover1253.19%IV95.30%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier15DDays to Expiry0.50Extrinsic Value100Contract SizeAmericanOptions Type-0.0136Delta0.0013Gamma21.28Leverage Ratio-0.0318Theta-0.0002Rho-0.29Eff Leverage0.0008Vega
Outset Medical Newsroom
RBC Capital Maintains Outset Medical(OM.US) With Hold Rating, Cuts Target Price to $12
Analysts Conflicted on These Healthcare Names: Outset Medical (OM) and AptarGroup (ATR)
TD Cowen Maintains Outset Medical(OM.US) With Buy Rating, Cuts Target Price to $15
Positive Outlook for Outset Medical: Buy Rating and $15 Price Target Amid Share Adjustments and Market Trends
Stifel Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $15
Analysts Offer Insights on Healthcare Companies: Opthea Limited (OtherCKDXF), Outset Medical (OM) and Maravai Lifesciences Holdings (MRVI)
BTIG Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $45
Stifel Maintains Outset Medical(OM.US) With Buy Rating, Cuts Target Price to $15
BTIG Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $45
Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunovant (IMVT), Summit Therapeutics (SMMT) and Outset Medical (OM)
RBC Capital Maintains Outset Medical(OM.US) With Hold Rating, Maintains Target Price $3
Stifel Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $6
Stifel Nicolaus Sticks to Its Buy Rating for Outset Medical (OM)
RBC Capital Maintains Outset Medical(OM.US) With Hold Rating, Maintains Target Price $3
RBC Capital Remains a Hold on Outset Medical (OM)
TD Cowen Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $3
Positive Outlook and Strong Financial Position Lead to Buy Rating for Outset Medical
BTIG Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $3
BTIG Remains a Buy on Outset Medical (OM)
BTIG Maintains Outset Medical(OM.US) With Buy Rating, Maintains Target Price $3
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now